Insilico Medicine vs Synthetic Sciences
Relationship
MMAI Gym and Ascent both list model training; both also serve buyers who need to train or fine-tune a model; Synthetic Sciences's scale not recorded; ships AI agent and agent platform rather than the same layer.
Assembled from the recorded fields for this pair, not hand-checked. The comparison below is read from each company’s own profile.
3 shared capabilities — Across all their products, both list agent orchestration, data analysis and model training.
Ludbee capability tags · every product each company sellsDifferent layer — Synthetic Sciences ships AI agent and agent platform, not the same layer.
Ludbee product recordsAligned comparison
Capability overlap
Shared · 3
Not verified for Synthetic Sciences · 5
Recorded for Insilico Medicine. Synthetic Sciences’s product records say nothing either way — a missing record is not a missing capability.
Synthetic Sciences has no capability Insilico Medicine lacks, among the 3 recorded here.
Products, side by side
Algorithmic pairing — assembled from recorded fields, not hand-checked
Insilico Medicine
No shared stack layer with the other side.
Synthetic Sciences
No shared stack layer with the other side.
No counterpart
Insilico Medicine sells these in a stack layer with no product recorded for Synthetic Sciences yet — nothing on the other side to compare them against.
Application
AI research writing assistant that drafts structured, cited papers, reviews, grant proposals and abstracts against biomedical databases such as PubMed and bioRxiv.
Multimodal AI platform that forecasts the probability of success of individual clinical trials and scores alternative trial designs before implementation.
Platform
AI platform for de novo design and multi-property optimization of peptides, nanobodies and antibodies against specified targets and epitopes.
Generative small-molecule design platform combining de novo generation with physics-based methods, retrosynthesis, ADMET profiling and custom model training.
Foundation-model training and benchmarking platform that fine-tunes a customer's own LLM on Insilico's proprietary pharma reasoning datasets and validates results in its automation lab.
AI platform for therapeutic target identification, biomarker discovery, indication prioritization and drug repurposing over a multi-omics knowledge base.
End-to-end generative-AI platform spanning target discovery, molecular design and clinical-trial risk assessment for pharmaceutical research.
Hardware
On-premise AI appliance running PandaOmics target and biomarker discovery locally with no external data transmission, sold in Server and Desktop editions.
Synthetic Sciences sells these in a stack layer with no product recorded for Insilico Medicine yet — nothing on the other side to compare them against.
AI agent
Open-source AI workbench for scientific research that brings literature, code, experiments, compute and results into one workspace; the company also runs Atlas (infrastructure for autonomous, open science), Ascent (agents that plan and run experiments across a user's compute) and FrontierRSI (an evaluation of agents at autonomous ML research), and its Ace service sells managed model access prepaid and pay as you go.
Agent platform
Platform for frontier AI research whose agents survey the literature, draft an experimental plan, run experiments in parallel across the customer's compute, monitor every run and report results, with swarms of agents that hillclimb a metric overnight and a Slack integration for launching and approving runs; access is by request and described as invite-only, no prices published.